Release Date: 06/08/19 09:02 Summary: ATL FY19 Results Release Date Price Sensitive: No Download Document 797.36KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%